Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960043/S131

Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

Abbott Vascular, Inc. · Decision date Mar 2, 2026

FDA DECISIONP960043/S131

What did the FDA decide?

FDA records P960043/S131 as a supplement to PMA P960043, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 2, 2026.

FDA approval order statement

a modification to the sustainable ethylene oxide (SEO) cycle previously approved for Line 1, Line 2, Line 14 and Line 15 at Synergy Health Ireland and implementation of the SEO cycle at Sterigenics Los Angeles
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Mar 2, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P960043/S131
Regulatory pathway
PMA supplement
Product code
MGB
Decision code
OK30
Decision date
Mar 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

For the original device and its historical approval scope, see PMA P960043. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960043 · Original PMA

    PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM

  2. P960043/S127 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Prostar XL Percutaneous Vascular Surgical System

  3. P960043/S131 received

    Application receipt date recorded by FDA.

  4. P960043/S129 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  5. P960043/S130 · Related supplement

    Perclose ProGuide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  6. P960043/S131 · FDA decision

    30-Day Notice

  7. P960043/S132 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  8. P960043/S133 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  9. P960043/S134 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  10. P960043/S136 · Related supplement

    Perclose ProStyle Suture-Mediated Closure and Repair System

  11. P960043/S128 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System and Perclose ProStyle Suture-Mediated Closure and Repair System

  12. P960043/S137 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  13. P960043/S138 · Related supplement

    Perclose ProStyle Suture-Mediated Closure and Repair System

  14. P960043/S139 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

Timeline entries are records held by MedtechLedger for P960043. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960043

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular, Inc.PMA approvalApr 30, 1997FDA
Abbott Vascular, Inc.PMA supplementDec 9, 2025FDA
Abbott Vascular, Inc.PMA supplementFeb 10, 2026FDA
Abbott Vascular, Inc.PMA supplementFeb 11, 2026FDA
Abbott Vascular, Inc.PMA supplementApr 1, 2026FDA
Abbott Vascular, Inc.PMA supplementApr 17, 2026FDA
Abbott Vascular, Inc.PMA supplementMay 22, 2026FDA
Abbott Vascular, Inc.PMA supplementJul 14, 2026FDA
Abbott Vascular, Inc.PMA supplementAug 27, 2026FDA
Abbott Vascular, Inc.PMA supplementSep 24, 2026FDA
Abbott Vascular, Inc.PMA supplementOct 26, 2026FDA
Abbott Vascular, Inc.PMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code MGB

Product / regulatory recordCompanyPathwayDecision dateSource
Vasorum, Ltd.PMA supplementOct 30, 2026FDA
Vivasure Medical , Ltd.PMA approvalOct 16, 2026FDA
Cardiva Medical, Inc.PMA supplementSep 10, 2026FDA
Terumo Medical CorporationPMA supplementAug 4, 2026FDA
Cordis US CorporationPMA supplementJun 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
400 Saginaw Dr., Redwood, CA, 94063

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records